SEPROT
  • CURSOS Y CONGRESOS
  • TRABAJO
  • BECAS
  • PUBLICACIONES
  • QUIÉNES SOMOS
  • SOCIOS

Article: Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease. E Santamaría’s Lab (UPNA-IdiSNA)

2 September, 2021Articulos Socios SEProt, Newsadmin

Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease
Isidro Ferrer, Pol Andrés-Benito, Karina Ausín, Reinald Pamplona, José Antonio Del Rio, Joaquín Fernández-Irigoyen, Enrique Santamaría

Brain Pathology (2021); DOI: 10.1111/bpa.12996

Abstract:

Tau hyperphosphorylation is the first step of neurofibrillary tangle (NFT) formation. In the present study, samples of the entorhinal cortex (EC) and frontal cortex area 8 (FC) of cases with NFT pathology classified as stages I-II, III-IV, and V-VI without comorbidities, and of middle-aged (MA) individuals with no NFT pathology, were analyzed by conventional label-free and SWATH-MS (sequential window acquisition of all theoretical fragment ion spectra mass spectrometry) to assess the (phospho)proteomes. The total number of identified dysregulated phosphoproteins was 214 in the EC, 65 of which were dysregulated at the first stages (I-II) of NFT pathology; 167 phosphoproteins were dysregulated in the FC, 81 of them at stages I-II of NFT pathology. A large percentage of dysregulated phosphoproteins were identified in the two regions and at different stages of NFT progression. The main group of dysregulated phosphoproteins was made up of components of the membranes, cytoskeleton, synapses, proteins linked to membrane transport and ion channels, and kinases. The present results show abnormal phosphorylation of proteins at the first stages of NFT pathology in the elderly (in individuals clinically considered representative of normal aging) and sporadic Alzheimer’s disease (sAD). Dysregulated protein phosphorylation in the FC precedes the formation of NFTs and SPs. The most active period of dysregulated phosphorylation is at stages III-IV when a subpopulation of individuals might be clinically categorized as suffering from mild cognitive impairment which is a preceding determinant stage in the progression to dementia. Altered phosphorylation of selected proteins, carried out by activation of several kinases, may alter membrane and cytoskeletal functions, among them synaptic transmission and membrane/cytoskeleton signaling. Besides their implications in sAD, the present observations suggest a molecular substrate for “benign” cognitive deterioration in “normal” brain aging.

Enlace: DOI:10.1111/bpa.12996

Previous post Postdoc SUMO & Ubiquitin in the Cell Cycle – Leiden University Medical Center Next post Article: Multiomics Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers. R Barderas’s Lab (ISCIII)

ESTAMOS EN

Facebook
Twitter

LO ÚLTIMO

  • VII Meeting for young proteomics researchers
  • Article: Multiomics Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers. R Barderas’s Lab (ISCIII)
  • Article: Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease. E Santamaría’s Lab (UPNA-IdiSNA)

OFERTAS DE TRABAJO

  • Postdoc SUMO & Ubiquitin in the Cell Cycle – Leiden University Medical Center
  • Postdoc functional proteomics and cell signaling, Blagoy-Blagoev Lab, SDU – Denmark
  • Postdoc at MC Durán Lab, INIBICA-UCA, Cádiz

CURSOS Y CONGRESOS

  • VII Meeting for young proteomics researchers
  • Weminar: Infection Medicine, New-old approaches & perspectives

CONTACT

Sociedad Española de Proteómica C/. Jaime Roig 11 46010 Valencia
secretaria@seprot.es

ESTAMOS EN

Facebook
Twitter

SOCIAL NETWORKS

Facebook
Twitter

ARCHIVO

Desde 2005…

NEWS

  • VII Meeting for young proteomics researchers
  • Article: Multiomics Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers. R Barderas’s Lab (ISCIII)
  • Article: Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease. E Santamaría’s Lab (UPNA-IdiSNA)

LINKS

EuPa
Aviso Legal | Diseño Prisma
Esta web utiliza cookies para mejorar su experiencia Acepto Leer más
Política de cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT